Senior insider sale
ORUKA THERAPEUTICS, INC. — senior position signals high conviction
$300.01M
3.55M shares
What this filing means
FAIRMOUNT FUNDS MANAGEMENT LLC plans to sell 3.55M shares of ORUKA THERAPEUTICS, INC. valued at approximately $300.01M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2026ACC: 0001104659-26-080011
Director10% Owner
Since Aug 2024
3.55M
Shares to sell
$300.01M
Approx. market value
3.55M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Conversion of Series B Non-Voting Convertible Preferred Stock
Conversion of Series B Non-Voting Convertible Preferred Stock into Common Stock
7/1/2026
3.55MTotal acquired3.55M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Conversion of Series B Non-Voting Convertible Preferred Stock Conversion of Series B Non-Voting Convertible Preferred Stock into Common Stock | 3.55M | — |
| Total | 3.55M | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.55M
Market value
$300.01M
7/1/2026
Total
Units
3.55M
Value
$300.01M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/1/2026 | 3.55M | $300.01M | NASDAQ | Planned |
| Total | 3.55M | $300.01M | ||